Li Wu

Dr. Li Wu


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2013 in Mobile DNA
Verified
Journal Article
Open access
PDF file
MAMichael Abebe
Michael Abebe
MCManuel A Candales
Manuel A Candales
ADAdrian Duong
Adrian Duong
KHKeyar S Hood
Keyar S Hood
TLTony Li
Tony Li
SZSteven Zimmerly
Steven Zimmerly
Accurate and complete identification of mobile elements is a challenging task in the current era of sequencing, given their large numbers and frequent truncations. Group II intron retroelements, which consist of a ribozyme and an intron-encoded protein (IEP), are usually identified in bacterial genomes through their IEP; however, the RNA component that defines the intron boundaries is often difficult to identify because of a lack of strong sequence conservation corresponding to the RNA structure. Compounding the problem of boundary definition is the fact that a majority of group II intron copies in bacteria are truncated.

19 September 2022 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
ZLZhijie Lv
Zhijie Lv
LWLi Wu
Li Wu
YLyan lu
yan lu
SLShan Liu
Shan Liu
LQli qiushuang
li qiushuang

27 April 2021 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
ZLZhijie Lv
Zhijie Lv
XZXiaoqi Zhang
Xiaoqi Zhang
LWLi Wu
Li Wu
Background: Infliximab-induced seizures in patients with Crohn’s disease are extremely rare and the mechanism of infliximab-induced seizures is unclear. Case presentation: A 60-year-old woman with Crohn’s disease experienced infliximab-induced seizures, diagnosed on normal magnetic resonance imaging of the brain. Moreover, the rechallenge with infliximab was positive. Conclusions: Neurological assessment and tight clinical monitoring before and during therapy with infliximab should be performed in patients with pre-existing seizure disorders.

9 September 2022 in Medicine
Verified
Journal Article
Open access
HYHuadi Yang
Huadi Yang
XJXuelu Bm Jiang
Xuelu Bm Jiang
TCTing Mm Chen
Ting Mm Chen
ZYZhitao Yao
Zhitao Yao
XXXuqun Bm Xu
Xuqun Bm Xu
XZXiaojing Mm Zhu
Xiaojing Mm Zhu
To evaluate the feasibility and efficiency of our novel technique, ultrasound guided hysteroscopic catheter dilation (US-HCD), for the treatment of moderate to severe intrauterine adhesion (IUA). A total of 126 patients diagnosed with IUA and met the enrollment criteria were admitted in this historical cohort study from June 1, 2016 to December 31, 2018. All patients were divided into 2 groups according to the surgical techniques used. Group A (n = 68) were treated with traditional hysteroscopic adhesiolysis with scissors (THA) and Group B (n = 58) were treated with US-HCD. Their data for the next 2 years following the initial surgery were analyzed. Safety and feasibility (operation time, surgical complications and the third-look hysteroscopic surgery rate), and post-operation efficacy (reduction of American Fertility Society [AFS] scores, pregnancy and live birth rates) were evaluated between groups. Between the groups, there was no statistically significant differences in basic preoperative information and AFS scores (P > .05). While there were significant differences in the operation time of the initial surgery (P < .05) and reduction of AFS scores (P < .05). No surgical complications were recorded and only 3 patients (5.2%) received a third-look hysteroscopy in Group B, while there were 6 cases of complications and 13 cases (19.1%) of third-look hysteroscopy in Group A, indicating significant differences between Groups (P < .05). Both groups exhibited comparable pregnancy rate, live birth rate and obstetric complications (P > .05). Our new technique is a safe, feasible and effective procedure for moderate to severe IUA patients, which can be mastered more quickly and easily by surgeons and applied in areas with less affluent economy and without hysteroscopic scissors, thus worthy of further study.